This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Zhejiang Doer Biologics Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Yali Lu: Innovator in Anti-CLD18A2 VHH Development
Introduction
Yali Lu is a prominent inventor based in Hangzhou, China. She has made significant contributions to the field of biology, particularly in the development of heavy-chain antibodies. Her innovative work focuses on anti-CLD18A2 VHHs, which have potential applications in tumor suppression.
Latest Patents
Yali Lu holds a patent titled "Heavy-chain antibodies (VHHs) against claudin 18A2 and use thereof." This patent describes an anti-CLD18A2 VHH that can specifically bind to the epitope on CLD18A2. The complementarity determining region (CDR) of this VHH includes CDR1, CDR2, and CDR3 with specific amino acid sequences. The corresponding fusion protein demonstrates good specificity and affinity for CLD18A2, showcasing a noticeable tumor suppression effect.
Career Highlights
Throughout her career, Yali Lu has worked with notable companies, including Zhejiang Doer Biologics Co., Ltd. and Zhejiang Doer Biologics Corporation. Her experience in these organizations has contributed to her expertise in biological innovations.
Collaborations
Yali Lu has collaborated with esteemed colleagues, including Gaofeng Yao and Zhenxing Zhou. These partnerships have further enhanced her research and development efforts in the field.
Conclusion
Yali Lu's contributions to the development of anti-CLD18A2 VHHs highlight her innovative spirit and dedication to advancing biological research. Her work has the potential to make a significant impact in the field of tumor suppression.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile